,33,278, 279, 280 It is foreseeable that creative agents (siRNAs, small molecule inhibitors, nanobody, etc.)will be developed to specifically inhibit FSCN1-mediated tumor metastasis. This evidence concerns the gene FSCN1 and neoplasm.